Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
Michael Shapiro, President of American Society for Preventive Cardiology (ASPC), shared Carlos Andrés Vergara Sánchez‘s post on LinkedIn, adding:
“Grateful to Carlos Andrés Vergara Sánchez for the generous words. Seeing fellows and early-career colleagues engage deeply in preventive cardiology is exactly why we launched these efforts.
At the American Society for Preventive Cardiology (ASPC), we are committed to creating real pathways for trainees who want to build careers in prevention.
The ASPC Training Academy and the AJPC Academy are two examples of how we are investing in mentorship, scholarship, and leadership development.
If you are interested in preventive cardiology, I encourage you to get involved. The future of the field depends on you.
Khurram Nasir and Carlos Andrés Vergara Sánchez, thank you for your leadership and partnership.”
Carlos Andrés Vergara Sánchez, Chief Cardiovascular Disease Fellow at Mayo Clinic College of Medicine and Science, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“The American Journal of Preventive Cardiology and American Society for Preventive Cardiology are investing in the future of academic preventive cardiology.
Under the leadership of Dr Michael Shapiro and Dr Khurram Nasir, their commitment to supporting trainees and early-career physicians has never been more tangible — all in service of better science and better patient care.
I’ve had the privilege of witnessing firsthand the energy and intention behind this effort.
The AJPC Academy is turning vision into opportunity for colleagues across the country.
Honored to be part of this incredible initiative.
Read more in the new publication”
Tilte: AJPC academy: A four-pillar model for cultivating the next generation of academic leaders in cardiovascular prevention
Authors: Carlos Vergara Sanchez, Ramzi Dudum, Michael D. Shapiro, Khurram Nasir
Read the Full Article on American Journal of Preventive Cardiology.
Stay updated with Hemostasis Today.
-
Aug 27, 2026, 00:04John Cush: Registry Study Confirms Real-World Liver Risks with Avacopan
-
Aug 26, 2026, 23:57N. Mariana S. Vasquez: TTP vs ITP vs DIC
-
Aug 26, 2026, 23:49Mauricio Ambriz: Pathogenesis of Autoimmune Hemolytic Anemia Mediated by Warm and Cold Antibodies
-
Aug 26, 2026, 23:45Can Thromboinflammation Biomarkers Improve PE Mortality Prediction? – RPTH Journal
-
Aug 26, 2026, 23:44From Almost Universally Fatal to Largely Treatable iTTP – American Society of Hematology
-
Aug 26, 2026, 23:39Eric Topol: Shingles Vaccine Associated with 10% Drop in Heart Failure and Stroke
-
Aug 26, 2026, 22:59Debbe McCall: Should Frail Elderly Patients Stable on Warfarin Switch to DOACs?
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero